IMPACT OF THE COVID-19 PANDEMIC ON THE COURSE OF ALLERGIC DISEASES

Authors

DOI:

https://doi.org/10.31435/ijitss.1(49).2026.5205

Keywords:

COVID-19, Allergic Diseases, Atopic Dermatitis, Asthma

Abstract

Background: The COVID-19 pandemic affected millions worldwide, especially those with chronic diseases. Both direct effects of SARS-CoV-2 infection and indirect consequences, such as restrictions and changes in healthcare access, significantly challenged daily life and disease management. Allergic diseases like atopic dermatitis (AD) and asthma were particularly vulnerable, as their course is highly influenced by biological and environmental factors.

Aim: This study analyzes the impact of the COVID-19 pandemic on the course of AD and asthma, based on available scientific literature.

Material and methods: A narrative review of current literature was conducted, focusing on studies examining the relationship between SARS-CoV-2 infection, pandemic restrictions, and the clinical course of atopic dermatitis and asthma. The review emphasized disease exacerbations, healthcare access, psychological factors, and the impact of pharmacological treatments.

Results: Patients with AD experienced symptom exacerbations due to increased psychological stress, lifestyle changes, frequent use of detergents, and restricted access to care. For asthma, severe or poorly controlled disease increased the risk of adverse COVID-19 outcomes, while well-controlled asthma did not worsen prognosis. Inhaled corticosteroids (ICS) and biological therapies did not increase the risk of COVID-19 complications and may have offered protective effects.

Conclusions: The COVID-19 pandemic worsened allergic diseases by increasing stress, reducing healthcare access, and changing lifestyles. Severe asthma raised the risk of poor outcomes, but well-controlled asthma did not. Inhaled corticosteroids and biologics were safe and possibly protective. Ongoing treatment and attention to psychosocial factors remain essential for managing allergic diseases during such public health crises.

References

Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., Abedi, A., Abedi, P., Abegaz, K. H., Abolhassani, H., Abosetugn, A. E., Aboyans, V., Abrams, E. M., Abreu, L. G., Abrigo, M. R. M., ... Murray, C. J. L. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9

Arndt, J., Smith, N., & Tausk, F. (2008). Stress and atopic dermatitis. Current Allergy and Asthma Reports, 8(4), 312–317. https://doi.org/10.1007/s11882-008-0050-6

Gans, M. D., & Gavrilova, T. (2020). Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatric Respiratory Reviews, 36, 118–127. https://doi.org/10.1016/j.prrv.2019.08.002

Hernández, N., Sanclemente, G., Tamayo, L., López, Á., & Seidel, A. (2021, August). Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part I. Prophylaxis, topical treatment an.... World Allergy Organization Journal. https://doi.org/10.1016/j.waojou.2021.100571

Hernández, N., Sanclemente, G., Tamayo, L., López, Á., Seidel, A., Hernandez, N., Chaparro, D., Cortes, A., Seidel, Á., Ortiz, C. I., Arenas, C., Meléndez, E., Amador, J., Colmenares, L., Guzmán, M. C., Torres, M. C., Tavera, M., Torres, M., Vargas, M., ... Cárdenas, P. (2021). Atopic dermatitis in the COVID-19 era: Results from a web-based survey. World Allergy Organization Journal, 14(8), Article 100571. https://doi.org/10.1016/j.waojou.2021.100571

Pourani, M. R., Ganji, R., Dashti, T., Dadkhahfar, S., Gheisari, M., Abdollahimajd, F., & Shahidi Dadras, M. (2022). Impact of COVID-19 pandemic on patients with atopic dermatitis. Actas Dermo-Sifiliográficas, 113(3), 286–293. https://doi.org/10.1016/j.ad.2021.08.013

Wecker, H., Tizek, L., Ziehfreund, S., Kain, A., Traidl-Hoffmann, C., Zimmermann, G. S., Scala, E., Elberling, J., Doll, A., Boffa, M. J., Schmidt, L., Sikora, M., Torres, T., Ballardini, N., Chernyshov, P. V., Buters, J., Biedermann, T., & Zink, A. (2023). Impact of asthma in Europe: A comparison of web search data in 21 European countries. World Allergy Organization Journal, 16(8), Article 100805. https://doi.org/10.1016/j.waojou.2023.100805

Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society, & Polish Society of Family Medicine. (2019). Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations. Part I: Prevention, topical treatment and phototherapy. Przegląd Dermatologiczny, 106(4), 354–374. https://doi.org/10.5114/dr.2019.88253

Downloads

Published

2026-03-25

How to Cite

Zuzanna Michalik, Klaudia Kapelka, Stanisław Malik, Przemysław Paduch, Zofia Bułka, Joanna Mazur, Dawid Kłos, Duszan Leja, Klaudia Czech, Kaja Zdrojewska, & Lena Apanowicz. (2026). IMPACT OF THE COVID-19 PANDEMIC ON THE COURSE OF ALLERGIC DISEASES. International Journal of Innovative Technologies in Social Science, 3(1(49). https://doi.org/10.31435/ijitss.1(49).2026.5205